Gene therapy to restore color vision in complete achromatopsia patients shows modest improvement

Researchers at the Hebrew University of Jerusalem, Israel, have attempted to restore color vision to completely color-blind subjects using gene therapy. In their paper, “Seeing color following gene augmentation therapy in Achromatopsia,” published in Current Biology, the team details the approach’s success and limitations on achromatopsia patients lacking a functioning CNGA3 gene.